Source link : https://newshealth.biz/health-news/melanoma-vaccine-halves-risk-of-recurrence-metastasis-over-5-years/
CHICAGO — An investigational individualized vaccine for surgically resected melanoma demonstrated durable benefits in reducing the risks of recurrence and distant spread, 5-year follow-up of a randomized study showed. Adding the mRNA vaccine intismeran autogene to pembrolizumab (Keytruda) in resected stage IIIB-IV melanoma cut the risk of recurrence or death by 49% (HR 0.51, 95% […]
The post Melanoma Vaccine Halves Risk of Recurrence, Metastasis Over 5 Years first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-02 18:52:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8